Sanofi Asset Resilience Ratio

Latest as of December 2024: 0.37%

Sanofi asset resilience ratio. Sanofi (SNW2) has an Asset Resilience Ratio of 0.37% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SNW2 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€486.00 Million

≈ $568.19 Million USD Cash + Short-term Investments

Total Assets

€132.80 Billion

≈ $155.25 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Sanofi (2016–2024)

Asset resilience ratio of Sanofi from 2016 to 2024. This chart shows how Sanofi's Asset Resilience Ratio has changed over time. Read SNW2 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Sanofi's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Sanofi's balance sheet.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€486.00 Million	0.37%
Total Liquid Assets	€486.00 Million	0.37%

Asset Resilience Insights

Limited Liquidity: Sanofi maintains only 0.37% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Sanofi Industry Peers by Asset Resilience Ratio

Compare Sanofi's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biogen Inc NASDAQ:BIIB	Drug Manufacturers - General	0.00%
Merck & Company Inc NYSE:MRK	Drug Manufacturers - General	0.22%
AstraZeneca PLC MX:AZNN	Drug Manufacturers - General	0.03%
Novartis AG SW:NOVN	Drug Manufacturers - General	0.08%
Pfizer Inc NYSE:PFE	Drug Manufacturers - General	5.33%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	5.33%
GuangYuYuan Chinese Herbal Medicine Co Ltd SHG:600771	Drug Manufacturers - General	1.97%
Dimed S.A. Distribuidora de Medicamentos SA:PNVL3	Drug Manufacturers - General	6.34%

Sanofi Asset Resilience Ratio by Year (2016–2024)

Sanofi asset resilience ratio by year from 2016 to 2024. The table below shows the annual Asset Resilience Ratio data for Sanofi.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.37%	€486.00 Million ≈ $568.19 Million	€132.80 Billion ≈ $155.25 Billion	+0.15pp
2023-12-31	0.21%	€270.00 Million ≈ $315.66 Million	€126.46 Billion ≈ $147.85 Billion	-0.32pp
2022-12-31	0.53%	€664.00 Million ≈ $776.29 Million	€124.58 Billion ≈ $145.65 Billion	-0.34pp
2021-12-31	0.88%	€1.05 Billion ≈ $1.23 Billion	€120.24 Billion ≈ $140.58 Billion	+0.09pp
2020-12-31	0.79%	€900.00 Million ≈ $1.05 Billion	€114.53 Billion ≈ $133.90 Billion	+0.41pp
2019-12-31	0.38%	€426.00 Million ≈ $498.04 Million	€112.74 Billion ≈ $131.80 Billion	+0.20pp
2018-12-31	0.18%	€199.00 Million ≈ $232.65 Million	€111.41 Billion ≈ $130.25 Billion	+0.10pp
2017-12-31	0.08%	€77.00 Million ≈ $90.02 Million	€99.83 Billion ≈ $116.71 Billion	+0.05pp
2016-12-31	0.03%	€31.00 Million ≈ $36.24 Million	€104.67 Billion ≈ $122.37 Billion	--

pp = percentage points

About Sanofi

F:SNW2 Germany Drug Manufacturers - General

Market Cap

$113.02 Billion

€96.67 Billion EUR

Market Cap Rank

#239 Global

#45 in Germany

Share Price

€39.80

Change (1 day)

+5.29%

52-Week Range

€35.00 - €45.00

All Time High

€54.50